Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis

Gastroenterology

Volumn 134, Issue 4, 2008, Pages

  Friedrich Rust, Mireen ^a   Ong, Mei Fang ^b   Martens, Swantje ^b   Sarrazin, Christoph ^a   Bojunga, Joerg ^a   Zeuzem, Stefan ^a   Herrmann, Eva ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

EID: 41349094999     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.01.034     Document Type: Article

References (74)

1. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N Engl J Med 345 (2001) 41-52
2. Strader D.B., Wright T., Thomas D.L., et al. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology 39 (2004) 1147-1171
3. Lok A.S., and McMahon B.J. Chronic hepatitis B. Hepatology 45 (2007) 507-539
4. Bravo A.A., Sheth S.G., and Chopra S. Liver biopsy. N Engl J Med 344 (2001) 495-500
5. Bedossa P., Dargere D., and Paradise V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
6. Sandrin L., Fourquet B., Hasquenoph J.M., et al. Transient elastography: a new non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29 (2003) 1705-1713
7. Kettaneh A., Marcellin P., Douvin C., et al. Features associated with success rate and performance of Fibroscan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol 46 (2007) 628-634
8. Fraquelli M., Rigamonti C., Casazza G., et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 56 (2007) 968-973
9. Deeks J.J. Systematic reviews of evaluation of diagnostic and screening tests. BMJ 323 (2001) 157-162
10. Haynes R.B., and Wilczynski N.L. Optimal search strategies for retrieving scientifically strong studies of diagnosis from Medline: analytical survey. BMJ 328 (2004) 1040
11. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
12. Poynard T., Halfon P., Castera L., et al. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Aliment Pharmacol Ther 25 (2007) 733-739
13. Poynard T., Halfon P., Castera L., et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 53 (2007) 1615-1622
14. Whiting P., Rutjes A.W., Reitsma J.B., et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3 (2003) 25
15. Littenberg B., and Moses L.E. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making 13 (1993) 313-321
16. Carrion J.A., Navasa M., Bosch J., et al. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 12 (2006) 1791-1798
17. Castera L., Vergniol J., Foucher J., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
18. Colletta C., Smirne C., Fabris C., et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 42 (2005) 838-845
19. Corpechot C., El Naggar A., Poujol-Robert A., et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 43 (2006) 1118-1124
20. De Ledinghen V., Douvin C., Kettaneh A., et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 41 (2006) 175-179
21. Erhardt A., Lorke J., Vogt C., et al. Transient elastography for diagnosing liver cirrhosis. Dtsch Med Wochenschr 131 (2006) 2765-2769
22. Ganne-Carrie N., Ziol M., de Ledinghen V., et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 44 (2006) 1511-1517
23. Gomez-Dominguez E., Mendoza J., Rubio S., et al. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther 24 (2006) 513-518
24. Nahon P., Thabut G., Ziol M., et al. Liver stiffness measurement versus clinicians' prediction or both for the assessment of liver fibrosis in patients with chronic hepatitis C. Am J Gastroenterol 101 (2006) 2744-2751
25. Posthouwer D., Mauser-Bunschoten E.P., Fischer K., et al. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography. J Thromb Haemost 5 (2007) 25-30
26. Ziol M., Handra-Luca A., Kettaneh A., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41 (2005) 48-54
27. Foucher J., Chanteloup E., Vergniol J., et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55 (2006) 403-408
28. Takeda T., Yasuda T., Nakayama Y., et al. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. World J Gastroenterol 12 (2006) 7768-7773
29. Baldaia C., Serejo F., Marinho R., et al. Transient elastography in chronic hepatitis C-comparison between different noninvasive methods for liver fibrosis assessment. Hepatology 44 Suppl 1 (2006) 276A
30. Barrault C., Medkour F., Atanaiu C., et al. Non invasive assessment of liver graft fibrosis by transient elastography after liver transplantation. Hepatology 42 suppl 1 (2005) 485A-486A
31. Blanc P.L., Gabbuti A., Marino N., et al. Liver stiffness in chronic hepatitis C: will it modify the assessment of patients?. J Hepatol 46 suppl 1 (2007) S201A
32. Castera L., Van hecke A., Trimoulet P., et al. Independent validation and comparison with FibroScan, FibroTest and liver biopsy of clinical glycomics for the non invasive assessment of liver fibrosis in chronic hepatitis C. Hepatology 42 Suppl 1 (2005) 436A
33. Castera L., Foucher J., Le Bail B., et al. Prospective and independent validation of the Lok index for prediction of cirrhosis in patients with chronic hepatitis C: comparison with FibroScan, FibroTest and APRI. DDW (2006) (Abstract-ID: 552)
34. Chang J, Tan HH, Yew BS, et al. Transient elastography (FibroScan®) to assess hepatic fibrosis in Chinese with chronic hepatitis B. 17th Asian Pacific Association for the Study of Liver Conference 2007.
35. Chanteloup E., Foucher J., Castera L., et al. FibroScan® is a new non invasive method for the detection of cirrhosis and its complications in patients with chronic liver diseases. Results of a prospective study in 456 patients. Hepatology 40 suppl 1 (2004) 515A
36. Coco B., Oliveri F., Colombatto P., et al. Monitoring liver stiffness: a new tool to measure liver fibrosis during therapy. Hepatology 42 suppl 1 (2005) 435A
37. Coco B., Oliveri F., Colombatto B., et al. Liver stiffness measured by transient elastography: the influence of biochemical activity. J Hepatol 44 suppl 2 (2006) S196A
38. Corradi F., Piscaglia F., Tame R., et al. Staging of hepatic fibrosis by liver elastometry (FibroScan) in recurrent HCV infection in liver transplant recipients. J Hepatol 44 suppl 2 (2006) S59A
39. De Ledinghen V., Le Bail B., Rebouissoux L., et al. FibroScan® is a new non-invasive method for the diagnosis of liver fibrosis in children: a prospective comparison with FibroSure®, and liver biopsy. Hepatology 42 suppl 1 (2005) 472A
40. De Ledinghen V., Beaugrand M., Kelleher T.B., et al. Prediction of liver fibrosis in non-alcoholic steatohepatitis (NASH): risk factors and diagnostic potential of liver elasticity using FibroScan. J Hepatol 44 suppl 2 (2006) S39A
41. Foucher J., Vergniol J., Castera L., et al. Fibrosis evaluation in chronic liver diseases: comparison of FibroScan® with liver biopsy, FibroTest®, Forns score, APRI, hyaluronan, prothrombin time, and AST/ALT ratio. J Hepatol 42 suppl 2 (2005) 78A
42. Fraquelli M., Rigamonti C., Conte D., et al. Reproducibility of transient elastography (TE) in assessing hepatic fibrosis. Hepatology 44 suppl 1 (2006) 444A
43. Gaia S., Carenzi S., Brunello F., et al. Is liver stiffness measurement different in patients with NASH or with viral hepatitis?. J Hepatol 46 suppl 1 (2007) S268A
44. Ganne-Carrie N., De Ledinghen V., Douvin C., et al. Accuracy of liver stiffness measurement (LSM) for the diagnosis of cirrhosis in patients with chronic liver diseases (CLD): a study in 1345 patients. Hepatology 42 suppl 1 (2005) 338A
45. Gomez-Dominguez E., Jimenez-Ridruejo J.M., Monteagudo J.A.M., et al. Efficiency of liver stiffness measurement (FibroScan®) for the follow up of patients with primary biliary cirrhosis. Hepatology 44 suppl 1 (2006) 633A
46. Jeon S.W., Cho C.M., Park Y.D., et al. Correlation between liver elasticity measured by Fibroscan® and liver fibrosis assessed by histology; preliminary study in Korea. DDW (2006) (Abstract ID: S1610)
47. Khohkar A., Farnan R., MacFarlane C., et al. Liver stiffness and biomarkers: correlation with cirrhosis, portal hypertension and hepatic synthetic function. Hepatology 42 suppl 1 (2005) 433A
48. Kim K.M., Park S.H., Yu E.S., et al. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy people: a prospective study in potential living related liver donors. J Hepatol 44 (2006) S91A
49. Laharie D., Foucher J., Bernard P.H., et al. Assessment of cirrhosis and its severity by FibroScan and biochemical markers in alcoholic patients. DDW (2006) (Abstract ID: M1026)
50. Lewin M., Poujol-Robert A., Boelle P.Y., et al. Diffusion-weighted MR imaging for the diagnosis of liver fibrosis in patients with chronic hepatitis C. Hepatology 44 suppl 1 (2006) 280A-281A
51. Marcellin P., De Ledinghen V., Dhumeaux D., et al. Non-invasive assessment of liver fibrosis in chronic hepatitis B using FibroScan®. Hepatology 42 suppl 1 (2005) 715A-716A
52. Marin J.C., De la Cruz J., Fernandez I., et al. Prospective comparison between transient elastography (FibroScan), APRI and Forns test for assessing liver fibrosis in patients with histological features of NAFLD. J Hepatol 46 suppl 1 (2007) S275A
53. Miailhes P, Perrot G, Bailly F, et al. Prospective comparison of transient elastography and liver biopsy for the assessment of fibrosis in patients with HIV/HBV co-infection. 14th Conference on Retroviruses and Opportunistic Infections 2007.
54. Nahon P., Ziol M., De Ledinghen V., et al. Assessment of liver fibrosis using liver stiffness measurement (LSM) in patients with alcoholic liver disease. J Hepatol 46 suppl 1 (2007) S278A
55. Nguyen-Khac E., Robert B., Brevet M., et al. Assessment of asymptomatic liver fibrosis in alcohol abuser patients by transient elastography (FibroScan). J Hepatol 46 suppl 1 (2007) S280A
56. Palau R., Mal F., Christidis C., et al. Transient elastography a new non invasive method for assessment of liver fibrosis: results in patients with HCV chronic hepatitis. J Hepatol 38 suppl 2 (2003) 126A
57. Pares A., Caballeria L., Lazaro E., et al. Transient elastography: a new and useful non-invasive method for assessing liver damage progression in primary biliary cirrhosis. Hepatology 42 suppl 1 (2005) 464A
58. Rigamonti C., Donato M.F., Fraquelli M., et al. Evaluation of liver graft fibrosis by transient elastography (TE). Liver Transpl 12 (2006) C60A
59. Rigamonti C., Donato F., Fraquelli M., et al. Transient elastography (TE, FibroScan®) in the evaluation of recurrent disease after liver transplantation (LT). Hepatology 44 suppl 1 (2006) 195A
60. Serejo F., Marinho R., Costa A., et al. Transient elastography (FibroScan®) in chronic hepatitis C. Will it modify the assessment and the follow-up of treated patients?. Hepatology 44 suppl 1 (2006) 322A-323A
61. Servin-Abad L.A., Jeffers L.J., Bejarano P., et al. Correlation between liver histology, laparoscopic gross appearance and elasticity measured with the shear elasticity probe (FibroScan) in patients with chronic liver disease. Hepatology 44 suppl 1 (2006) 578A
62. Vergara S, Macías J, Rivero A, et al. Failure of transient elatometry (FibroScan) to differentiate mild from significant liver fibrosis in HIV/HCV-co-infected patients. 14th Conference on Retroviruses and Opportunistic Infections 2007.
63. Beaugrand M., Ziol M., Sandrin L., et al. Liver elasticity measurement by ultrasonic transient elastography: a new non-invasive method for assessment of liver fibrosis in chronic viral hepatitis. Hepatology 38 suppl 1 (2003) 438A-439A
64. Swets J.A. Measuring the accuracy of diagnostic systems. Science 240 (1988) 1285-1293
65. Ebell M.H. Probability of cirrhosis in patients with hepatitis C. Am Fam Physician 68 (2003) 1831-1833
66. Veldt B.J., Heathcote E.J., Wedemeyer H., et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med 147 (2007) 677-684
67. Siebert U., and Sroczynski G. Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Federal Ministry of Health and Social Security. Int J Technol Assess Health Care 21 (2005) 55-65
68. Sebastiani G., and Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 12 (2006) 3682-3694
69. Poynard T., Morra R., Halfon P., et al. Meta-analyses of Fibrotest diagnostic value in chronic liver disease. BMC Gastroenterol 7 (2007) 40
70. Poynard T., Munteanu M., Imbert-Bismut F., et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 50 (2004) 1344-1355
71. Coco B., Oliveri F., Maina A.M., et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 14 (2007) 360-369
72. Castera L., Le-Bail B., Foucher J., et al. Prospective analysis of discordance between FibroScan and FibroTest when used in combination as first-line assessment of liver fibrosis in chronic hepatitis C. Hepatology 42 suppl 1 (2005) 440A
73. Hui S.L., and Zhou X.H. Evaluation of diagnostic tests without gold standards. Stat Methods Med Res 7 (1998) 354-370
74. Ngo Y., Munteanu M., Messous D., et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 52 (2006) 1887-1896